BRIEF published on 06/04/2024 at 18:28, 5 months 18 days ago Funding Circle Plc: Share Buyback Announcement London Stock Exchange Share Buyback Share Cancellation Funding Circle Stock Repurchase
PRESS RELEASE published on 06/04/2024 at 18:23, 5 months 18 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces buy-back of 282,000 ordinary shares at prices between 89.80p and 92.20p per share on the London Stock Exchange London Stock Exchange Ordinary Shares Funding Circle Plc Share Cancellation Buy-back
BRIEF published on 06/03/2024 at 18:04, 5 months 19 days ago Funding Circle Plc Announces Buyback of Own Shares London Stock Exchange Ordinary Shares Share Buyback Numis Securities Funding Circle
PRESS RELEASE published on 06/03/2024 at 17:59, 5 months 19 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc announces the purchase and cancellation of 166,783 ordinary shares, part of the buy-back program, on the London Stock Exchange from Numis Securities Limited London Stock Exchange Share Buyback Numis Securities Limited Cancellation Funding Circle Plc
BRIEF published on 05/31/2024 at 17:59, 5 months 22 days ago Funding Circle Plc Announces Transaction in Own Shares Share Buy-back London Stock Exchange Transaction Numis Securities Funding Circle
PRESS RELEASE published on 05/31/2024 at 17:54, 5 months 22 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase of 169,278 ordinary shares for cancellation on the London Stock Exchange, part of its buy-back program London Stock Exchange Ordinary Shares Share Buyback Cancellation Funding Circle Plc
BRIEF published on 05/31/2024 at 11:49, 5 months 23 days ago Funding Circle Plc: TVR-Total Voting Rights Share Capital Disclosure And Transparency Rules Total Voting Rights Regulatory Announcement Funding Circle
PRESS RELEASE published on 05/31/2024 at 11:44, 5 months 23 days ago Funding Circle Plc: TVR-Total Voting Rights Funding Circle Plc announces Total Voting Rights as of 31-May-2024 in compliance with Disclosure and Transparency Rule 5.6.1 Shareholders Total Voting Rights Disclosure And Transparency Rule Funding Circle Plc Financial Conduct Authority
BRIEF published on 05/30/2024 at 17:56, 5 months 23 days ago Funding Circle Plc: Transaction in Own Shares London Stock Exchange Ordinary Shares Share Buyback Numis Securities Funding Circle
PRESS RELEASE published on 05/30/2024 at 17:51, 5 months 23 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase and cancellation of 92,652 ordinary shares as part of its buy-back program on 30 May 2024 Ordinary Shares Buy-back Program Share Purchase Cancellation Funding Circle Plc
Published on 11/22/2024 at 23:55, 11 hours 56 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 12 hours 21 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 12 hours 46 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 13 hours 21 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 17 hours 36 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 17 hours 57 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 18 hours 55 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 19 hours 51 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 4 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 16 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 18 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 18 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
